Cognito Therapeutics Ltd. — Form D
Cognito Therapeutics Ltd. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-02. The offering totals $60.0M, of which $10.2M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-07-02
- Form: D
- Accession: 0001936187-24-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $60.0M
- Amount sold: $10.2M
- Remaining: $49.8M
- Investors: 3
- Date of first sale: 2024-06-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-517621
Issuer
- Name: Cognito Therapeutics Ltd.
- CIK: 0001936187
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Address: 1218 MASSACHUSETTS AVE, CAMBRIDGE, MA, 02138
- Phone: 8572015088
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Laura Brege | Director | Foster City, CA |
| Stephen Bruso | Director | New Haven, CT |
| Gerald Chan | Director | Monaco, O9 |
| Jeffrey Halis | Director | Cambridge, MA |
| Richard Kuntz | Director | Boston, MA |
| Helen Liang | Director | Cambridge, MA |
| Brent Vaughan | Director | Cambridge, MA |
| Brent Vaughan | Executive Officer | Cambridge, MA |
| Stephen Ghiglieri | Executive Officer | Cambridge, MA |
| Zach Malchano | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More